Tag

Study Flaws

All articles tagged with #study flaws

Biostatistician Debunks Flawed Study Linking Vaccines to Chronic Illness

Originally Published 3 months ago — by The Conversation

Featured image for Biostatistician Debunks Flawed Study Linking Vaccines to Chronic Illness
Source: The Conversation

A flawed study claiming vaccines cause chronic illnesses in children is critically analyzed, revealing significant biases such as surveillance bias, detection bias, and confounding factors, which undermine its conclusions. The study's design issues, including unequal follow-up times and differences in healthcare utilization, prevent it from establishing a causal link between vaccines and long-term health risks.

Flawed Study by RFK Jr. Ally Links Vaccines to Chronic Illness

Originally Published 4 months ago — by statnews.com

Featured image for Flawed Study by RFK Jr. Ally Links Vaccines to Chronic Illness
Source: statnews.com

A flawed, unpublished study claiming vaccines increase chronic illnesses is criticized for fundamental methodological errors, particularly detection bias, and is contrasted with robust peer-reviewed research showing no such link. The article emphasizes the importance of proper scientific standards in informing public health policy and warns against political misuse of flawed data.

UnitedHealth Under DOJ Investigation Over Medicare Practices

Originally Published 5 months ago — by statnews.com

Featured image for UnitedHealth Under DOJ Investigation Over Medicare Practices
Source: statnews.com

A study funded by UnitedHealth's Optum subsidiary claiming higher-quality care for Medicare patients was criticized by independent experts for methodological flaws and potential bias, raising questions about the reliability of the findings and the company's influence in healthcare.

FDA Evaluates MDMA for PTSD Amid Safety Concerns and Study Issues

Originally Published 1 year ago — by The New York Times

Featured image for FDA Evaluates MDMA for PTSD Amid Safety Concerns and Study Issues
Source: The New York Times

The FDA has raised concerns about the health risks and study flaws in the use of MDMA, commonly known as Ecstasy, for treating PTSD. The agency's analysis highlighted issues such as bias in the studies and significant increases in blood pressure and pulse rates, which could lead to cardiovascular events. An independent advisory panel will review the application by Lykos Therapeutics for MDMA-assisted therapy next week. Approval of this treatment would represent a major shift in the regulation of psychedelic compounds.